Salvage colectomy for endoscopically removed malignant colon polyps: Is it possible to determine the optimal number of lymph nodes that need to be harvested?

Colorectal Disease

Volumn 14, Issue 1, 2012, Pages 79-86

  Benhaim, L ^a,b   Benoist, S ^a,b   Bachet, J B ^a,b   Julie C ^a,b   Penna, C ^a,b   Nordlinger, B ^a,b  

^a HÔPITAL AMBROISE PARÉ   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Colon cancer; Lymph nodes; Malignant polyp

Indexed keywords

AGED; ARTICLE; COLON CANCER; COLON POLYP; COLON RESECTION; ENDOSCOPIC SURGERY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SALVAGE THERAPY; SURGICAL TECHNIQUE;

AGED; CHI-SQUARE DISTRIBUTION; COLECTOMY; COLONIC POLYPS; COLONOSCOPY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PROSPECTIVE STUDIES; SALVAGE THERAPY; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 83255186824     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2011.02533.x     Document Type: Article

References (29)

1. Netzer P, Forster C, Biral R et al. Risk factor assessment of endoscopically removed malignant colorectal polyps. Gut 1998; 43: 669-74.
2. Ueno H, Mochizuki H, Hashiguchi Y et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 2004; 127: 385-94.
3. Conférence de Consensus. Conclusions et recommandations du jury. Texte de Consensus. Prévention, dépistage et prise en charge des cancers du côlon. Gastroenterol Clin Biol 1998; 22: S275-88.
4. Volk EE, Goldblum JR, Petras RE, Carey WD, Fazio VW. Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology 1995; 109: 1801-7.
5. Cooper HS, Deppisch LM, Gourley WK et al. Endoscopically removed malignant colorectal polyps: clinicopathologic correlations. Gastroenterology 1995; 108: 1657-65.
6. Maughan NJ, Morris E, Forman D, Quirke P. The validity of the Royal College of Pathologists' colorectal cancer minimum dataset within a population. Br J Cancer 2007; 97: 1393-8.
7. Compton CC, Fielding LP, Burgart LJ et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124: 979-94.
8. Sobin LH, Wittekind C. (2002) TNM Classification of Malignant Tumors UICC, 6th edition. Wiley-Liss, New York.
9. André T, Boni C, Navarro M et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009; 27: 3109-16.
10. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-13.
11. Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart A. Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. J Clin Oncol 2010; 28: 256-63.
12. Cserni G. Nodal staging of colorectal carcinomas and sentinel nodes. J Clin Pathol 2003; 56: 327-35.
13. Rosenberg R, Friederichs J, Schuster T et al. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3, 026 patients over a 25-year time period. Ann Surg 2008; 248: 968-78.
14. Le Voyer TE, Sigurdson ER, Hanlon AL et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 2003; 21: 2912-9.
15. Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg 2006; 244: 602-10.
16. Johnson PM, Porter GA, Ricciardi R, Baxter NN. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol 2006; 24: 3570-5.
17. Fielding LP, Arsenault PA, Chapuis PH et al. Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol 1991; 6: 325-44.
18. Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 2003; 10: 65-71.
19. Nelson H, Petrelli N, Carlin A et al. ; National Cancer Institute Expert Panel Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001; 93: 583-96.
20. Goldstein NS, Sanford W, Coffey M, Layfield LJ. Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodesto be recovered. Am J Clin Pathol 1996; 106: 209-16.
21. McPartland S, Hyman N, Blaszyk H, Osler T. The number of lymph nodes in colon cancer specimens: what do the numbers really mean? Colorectal Dis 2010; 12: 770-5.
22. Dillman RO, Aaron K, Heinemann FS, McClure SE. Identification of 12 or more lymph nodes in resected colon cancer specimens as an indicator of quality performance. Cancer 2009; 115: 1840-8.
23. West NP, Hohenberger W, Weber K, Perrakis A, Finan PJ, Quirke P. Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol 2010; 28: 272-8.
24. Eijsbouts QA, Heuff G, Sietses C, Meijer S, Cuesta MA. Laparoscopic surgery in the treatment of colonic polyps. Br J Surg 1999; 86: 505-8.
25. Bilimoria KY, Palis B, Stewart AK et al. Impact of tumor location on nodal evaluation for colon cancer. Dis Colon Rectum 2008; 51: 154-61.
26. Prandi M, Lionetto R, Bini A et al. Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial. Ann Surg 2002; 235: 458-63.
27. Ostadi MA, Harnish JL, Stegienko S, Urbach DR. Factors affecting the number of lymph nodes retrieved in colorectal cancer specimens. Surg Endosc 2007; 21: 2142-6.
28. Chin CC, Wang JY, Yeh CY, Kuo YH, Huang WS, Yeh CH. Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases in stage III colon cancer. Int J Colorectal Dis 2009; 24: 1297-302.
29. Ramirez M, Schierling S, Papaconstantinou HT, Scott Thomas J. Management of the malignant polyp. Clin Colon Rectal Surg 2008; 21: 286-90.